Of great clinical interest, synthetic ligands of PPARγ, belonging to the class of thiazolidinediones (TZDs), such as troglitazone, pioglitazone, and rosiglitazone, function as insulin sensitizers and are used for treating hyperglycemia in patients with type 2 diabetes [7, 18–20]. Here, INS is linked to type 2 diabetes mellitus.